PMC:7212236 / 0-437
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 45-52 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 63-71 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T2 | 101-109 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T3 | 216-240 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 242-250 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T5 | 377-385 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 260-265 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T2 | 269-274 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T3 | 289-290 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 45-52 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T2 | 53-59 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
| T3 | 337-342 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-73 | Sentence | denotes | State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2 |
| T2 | 75-83 | Sentence | denotes | Abstract |
| T3 | 84-96 | Sentence | denotes | Introduction |
| T4 | 97-314 | Sentence | denotes | The SARS-CoV-2 (previously 2019-nCoV) outbreak in Wuhan, China and other parts of the world affects people and spreads coronavirus disease 2019 (COVID-19) through human-to-human contact, with a mortality rate of > 2%. |
| T5 | 315-388 | Sentence | denotes | There are no approved drugs or vaccines yet available against SARS-CoV-2. |
| T6 | 390-410 | Sentence | denotes | Material and methods |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 9 | 101-111 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 10 | 124-133 | Species | denotes | 2019-nCoV | Tax:2697049 |
| 11 | 197-203 | Species | denotes | people | Tax:9606 |
| 12 | 260-265 | Species | denotes | human | Tax:9606 |
| 13 | 269-274 | Species | denotes | human | Tax:9606 |
| 14 | 377-387 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 15 | 216-240 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
| 16 | 242-250 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 17 | 291-300 | Disease | denotes | mortality | MESH:D003643 |